"text": "Cla is a compound that works through multiple biological pathways. Research shows it supports various aspects of health through its bioactive properties."

      "text": "Typical dosages range from the amounts used in clinical studies. Always consult with a healthcare provider to determine the right dose for your individual needs."

      "text": "Cla has been studied for multiple health benefits. Clinical research demonstrates effects on various body systems and functions."

      "text": "Cla is generally well-tolerated, but some people may experience mild effects. Consult a healthcare provider if you have concerns or pre-existing conditions."

      "text": "Cla can often be combined with other supplements, but interactions are possible. Check with your healthcare provider about your specific supplement regimen."

      "text": "Effects can vary by individual and the specific benefit being measured. Some effects may be noticed within days, while others may take weeks of consistent use."

      "text": "Individuals looking to support the health areas addressed by Cla may benefit. Those with specific health concerns should consult a healthcare provider first."

CLA Went From the Most Exciting Fat Loss Discovery in Decades to One of the Biggest Disappointments in Supplement History

#

In 1997, researchers at the University of Wisconsin-Madison published a study that sent shockwaves through the nutrition world. When they fed mice a diet containing just 0.5% conjugated linoleic acid, the animals lost 57 to 60% of their body fat compared to controls. Lean body mass increased by 5 to 14%. The results were so dramatic that they seemed almost too good to be true.

They were.

Nearly three decades later, CLA remains one of the best-selling fat loss supplements globally, generating an estimated $500 to $675 million in annual revenue. It sits in prominent positions on supplement store shelves, endorsed by fitness influencers and bodybuilding websites. The marketing typically references those spectacular animal studies and phrases like “clinically proven” appear on virtually every label.

But the human research tells a profoundly different story. When scientists moved from feeding CLA to mice and began running randomized controlled trials in humans, the dramatic fat-melting effects evaporated. What remained was a statistically significant but clinically trivial reduction in body fat that most people would never notice on a scale, in a mirror, or in how their clothes fit.

The most rigorous meta-analysis on the topic, published in the American Journal of Clinical Nutrition by Whigham and colleagues in 2007, pooled data from 18 randomized controlled trials and found that CLA supplementation produced an average fat loss of 0.09 kg per week compared to placebo. That is roughly 3 ounces per week, or about 0.8 pounds per month. The Onakpoya 2012 meta-analysis in the European Journal of Nutrition found an even smaller effect: a total fat mass reduction of just 1.33 kg over study durations averaging 6 to 12 months.

To put this in clinical perspective, the National Heart, Lung, and Blood Institute considers a minimum of 5% body weight loss to be clinically meaningful for health outcomes. For a 90 kg person, that means losing at least 4.5 kg. CLA’s best-case contribution of 1.33 kg over 6 to 12 months falls dramatically short of that threshold.

This article is a comprehensive, evidence-based analysis of CLA for weight loss and body composition. We examined four major meta-analyses, dozens of individual randomized controlled trials, and the mechanistic research to give you the complete picture. The answer is nuanced but ultimately clear: CLA has a real but extremely small effect on body fat, and for most people, the modest benefit does not justify the cost, the pill burden, or the potential safety concerns.

Watch Our Video Review

#

10 Signs Your Body Composition Might Need Attention

#

Before diving into what CLA can and cannot do, it is worth recognizing the signals that suggest your body composition may benefit from intervention. These are not signs that you need a supplement. They are signs that lifestyle factors like diet, exercise, sleep, and stress management deserve evaluation first.

1. Your waist circumference keeps increasing. A waist measurement above 102 cm (40 inches) for men or 88 cm (35 inches) for women is associated with increased cardiometabolic risk according to NHLBI guidelines, regardless of what the scale says.

2. You are gaining weight despite eating the same way you always have. Metabolic rate naturally declines with age and with loss of muscle mass. If the same habits are producing different outcomes, your energy balance has shifted.

3. You feel winded during activities that used to be easy. Excess body fat increases the metabolic cost of movement and can compress lung capacity. Declining physical capacity is often more related to body composition than to cardiovascular fitness alone.

4. Your blood work is trending in the wrong direction. Rising fasting glucose, increasing triglycerides, or declining HDL cholesterol are metabolic signals that body composition may be contributing to disease risk.

5. You have visible changes in fat distribution. Increased abdominal fat, a thickening midsection, or loss of visible muscle definition reflects shifts in the ratio of fat mass to lean mass.

6. Your energy levels have declined consistently. Excess body fat promotes chronic low-grade inflammation, which is associated with fatigue, poor sleep quality, and reduced daytime alertness.

7. Joint pain has increased, particularly in weight-bearing joints. Every extra kilogram of body weight places approximately 4 kg of additional force on the knee during walking. Excess fat mass is one of the strongest modifiable risk factors for osteoarthritis.

8. You are losing strength despite maintaining activity. If your strength is declining while your weight is stable or increasing, the composition of your body is shifting toward more fat and less muscle, a phenomenon sometimes called sarcopenic obesity.

9. Your recovery from exercise has slowed down. Excess adipose tissue is metabolically active and produces inflammatory cytokines that can impair recovery from physical stress.

10. Your clothes fit differently despite the scale staying the same. This is one of the clearest signs of body recomposition in the wrong direction: muscle loss being masked by fat gain, keeping total weight stable while body composition deteriorates.

If several of these apply to you, the evidence-based approach starts with caloric management, resistance training, adequate protein intake, and sleep optimization. These interventions each produce effect sizes that dwarf what any body composition supplement can deliver.

What Is CLA? Isomers, Natural Sources, and Supplement Forms

#

Conjugated linoleic acid is not a single compound. It is a family of at least 28 naturally occurring positional and geometric isomers of linoleic acid, an omega-6 fatty acid. The term “conjugated” refers to the arrangement of double bonds in the fatty acid chain: instead of being separated by a methylene group (as in standard linoleic acid), the double bonds in CLA are adjacent, creating a conjugated diene system.

The Two Isomers That Matter

#

Of the 28+ CLA isomers, only two have received significant research attention:

cis-9, trans-11 CLA (c9,t11): This is the predominant naturally occurring isomer, accounting for approximately 75 to 80% of total CLA in dairy products and ruminant meat. It is sometimes called “rumenic acid” because it is produced by bacterial biohydrogenation of linoleic acid in the rumen of cattle, sheep, and goats. Research suggests this isomer has anti-inflammatory and potentially anti-carcinogenic properties, but it has no meaningful effect on body fat or body composition.

trans-10, cis-12 CLA (t10,c12): This is the isomer responsible for the body fat-reducing effects seen in both animal and human studies. It is present in very small amounts in natural food sources (typically less than 10% of total dietary CLA) but is a major component of synthetic CLA supplements. This isomer is also the one linked to the safety concerns discussed later in this article, including insulin resistance and liver fat accumulation.

Natural Food Sources

#

CLA occurs naturally in the fat of ruminant animals. The richest dietary sources include:

• Grass-fed beef: Approximately 500 to 800 mg of CLA per 4-ounce (113 g) serving, with grass-fed containing roughly two to three times more CLA than grain-fed beef
• Whole milk: Approximately 5.5 mg of CLA per gram of milk fat
• Butter: One of the richest dairy sources, particularly from grass-fed cows
• Cheese: Hard cheeses contain meaningful amounts, especially those from pasture-raised animals
• Lamb: Comparable to beef in CLA content, with grass-fed varieties having higher concentrations

The critical point: the average dietary intake of CLA from food ranges from approximately 0.15 to 0.30 grams per day in most Western populations. Even a diet deliberately enriched with grass-fed dairy and meat provides roughly 0.5 to 1.5 grams per day. This is far below the 3.2 grams per day minimum dose used in most clinical trials, and the vast majority of dietary CLA is the c9,t11 isomer, not the t10,c12 isomer that reduces body fat.

Supplement Forms

#

CLA supplements are produced industrially through alkaline isomerization of linoleic acid, typically derived from safflower or sunflower oil. The most common branded forms are:

• Tonalin (now Clarinol): Produced by BASF, this is the most widely studied form. It contains approximately 80% CLA as a mixture of roughly equal parts c9,t11 and t10,c12 isomers in triglyceride form.
• Generic CLA softgels: Widely available and typically containing 1,000 to 1,300 mg of CLA per softgel, with a similar isomer ratio.

Standard dosing in clinical trials uses 3.0 to 3.4 grams of active CLA per day, typically divided across three doses taken with meals.

The Animal Study Promise vs. the Human Reality

#

The story of CLA is one of the most dramatic examples in nutritional science of animal research failing to predict human outcomes. Understanding this gap is essential for evaluating the supplement’s marketing claims.

The Mouse Studies That Started It All

#

In the landmark 1997 study by Park and colleagues at the University of Wisconsin-Madison, ICR mice were fed a diet containing either 5.5% corn oil (control) or 5.0% corn oil plus 0.5% CLA. After several weeks, the CLA-fed mice showed 57% and 60% lower body fat compared to controls, along with 5% to 14% increases in lean body mass. Mechanistically, the researchers found increased carnitine palmitoyltransferase (CPT-1) activity in both fat pads and skeletal muscle, and a 66% reduction in lipoprotein lipase activity in cultured adipocytes.

Subsequent animal studies produced similarly dramatic results. Mice given CLA showed reductions in body fat ranging from 40% to 70% in various experimental models. Some CLA-treated mice became so depleted of body fat that they entered torpor (a hibernation-like state) after short periods of fasting, suggesting CLA had essentially stripped away their energy reserves.

These results generated enormous excitement and rapidly attracted commercial interest.

Why Mouse Results Did Not Translate to Humans

#

Several biological factors explain the enormous gap between mouse and human outcomes:

Dose scaling. The doses used in mouse studies, when adjusted for body weight, were proportionally much higher than what is feasible or safe in humans. A 0.5% dietary CLA concentration in mice translates to a dose that far exceeds the 3 to 4 grams per day given to humans.

Metabolic rate differences. Mice have dramatically higher metabolic rates relative to body size compared to humans. Their entire metabolic machinery turns over faster, making them more responsive to metabolic interventions.

Brown adipose tissue. Mice have proportionally much more metabolically active brown fat than adult humans. CLA’s effects on uncoupling proteins and mitochondrial thermogenesis may be more pronounced in species with abundant brown adipose tissue.

Fat storage biology. The regulation of adipose tissue differs substantially between rodents and humans. Mouse adipocytes are more responsive to the anti-adipogenic signaling pathways that CLA activates.

Duration effects. Many mouse studies were short-term, capturing the initial dramatic response. Longer-term studies showed diminishing effects, a pattern that also appears in human research where benefits plateau after approximately 6 months.

The lesson is not that mouse studies are useless. They are valuable for identifying mechanisms and generating hypotheses. But the history of CLA is a textbook example of why “it works in mice” is never sufficient evidence to recommend a supplement to humans. The effect size in humans turned out to be roughly 1/50th to 1/100th of what was observed in rodents.

What the Meta-Analyses Actually Show: The Numbers Behind the Headlines

#

Four major meta-analyses have systematically evaluated CLA’s effects on body composition in humans. Their findings are consistent: CLA produces a statistically significant but clinically tiny reduction in body fat.

Whigham et al. (2007) – American Journal of Clinical Nutrition

#

This was the first comprehensive meta-analysis of CLA for fat loss in humans and remains one of the most cited.

Study details: 18 eligible randomized controlled trials were identified and included.

Primary finding: CLA at 3.2 g/day produced a fat mass reduction of 0.09 +/- 0.08 kg per week compared to placebo (P < 0.001). The dose-response relationship was -0.024 kg per gram of CLA per week (P = 0.03).

Time course: The fat loss effect was linear for approximately the first 6 months, after which it gradually approached an asymptote. By 2 years, additional fat loss had largely ceased.

What this means in practical terms: At 0.09 kg per week, CLA produces approximately 360 grams (0.8 pounds) of fat loss per month beyond placebo. Over 6 months, the theoretical maximum cumulative fat loss would be approximately 2.3 kg (5 pounds). In reality, the asymptotic pattern means the actual total is likely less than this.

Onakpoya et al. (2012) – European Journal of Nutrition

#

This systematic review specifically focused on long-term studies in overweight and obese individuals.

Study details: 15 RCTs identified, 7 included in the meta-analysis. The authors noted that 4 of the 7 included studies had serious methodological flaws.

Primary findings:

• Body weight difference: -0.70 kg (95% CI: -1.09 to -0.32) favoring CLA
• Fat mass difference: -1.33 kg (95% CI: -1.79 to -0.86) favoring CLA

The authors’ conclusion: “The magnitude of these effects is small, and the clinical relevance is uncertain. The evidence from RCTs does not convincingly show that CLA intake generates any clinically relevant effects on body composition on the long term.”

This is a critical point. The researchers who conducted the meta-analysis themselves stated that the results were not clinically meaningful, despite being statistically significant.

Schoeller et al. (2009) – Applied Physiology, Nutrition, and Metabolism

#

This meta-analysis specifically examined CLA’s effects on fat-free mass (lean body mass).

Study details: 18 studies included, all placebo-controlled trials with body composition measurements.

Primary finding: Fat-free mass increased by 0.3 +/- 0.7 kg during CLA treatment (P = 0.05). This change did not show a dose-response relationship and did not increase with longer treatment duration.

What this means: A 0.3 kg increase in lean mass is so small (less than 1% for an average adult) that it falls within the measurement error of most body composition assessment methods, including DEXA scans. The authors characterized the total increase as “small.”

Haghighat et al. (2024) – British Journal of Nutrition

#

This is the most recent and largest meta-analysis, providing the most comprehensive dataset available.

Study details: 70 randomized controlled trials with 4,159 total participants were included. The analysis incorporated dose-response modeling.

Overall findings: CLA supplementation significantly reduced body mass, BMI, waist circumference, fat mass, and body fat percentage, while modestly increasing fat-free mass.

Critical subgroup analysis: When the researchers restricted their analysis to high-quality studies only, CLA supplementation failed to show a significant effect on fat mass or body fat percentage. The apparent benefits seen in the overall analysis were driven primarily by lower-quality studies with higher risk of bias.

What this means: The most recent and rigorous analysis suggests that CLA’s fat-reducing effect may be even smaller than previously estimated, and may disappear entirely when only the best-designed studies are considered.

Putting the Numbers in Clinical Context

#

The NHLBI defines clinically meaningful weight loss as a minimum of 5% of initial body weight. Here is how CLA compares to that threshold:

For comparison, a modest caloric deficit of 500 calories per day produces approximately 0.45 kg (1 pound) of fat loss per week, which is 5 to 9 times the effect of CLA supplementation. Walking for 30 minutes daily burns roughly 150 to 200 extra calories, producing more fat loss than CLA over the same time period.

Key Individual RCTs Worth Knowing

#

Blankson et al. (2000) – Journal of Nutrition: 60 overweight/obese subjects randomized to placebo or CLA at 1.7, 3.4, 5.1, or 6.8 g/day for 12 weeks. Significant fat reduction was found in the 3.4 g and 6.8 g groups, but no additional benefit was seen above 3.4 g/day. This study established the commonly cited 3.2-3.4 g/day dose recommendation. PMID: 11110851

Gaullier et al. (2004) – American Journal of Clinical Nutrition: The longest CLA study at the time, lasting 12 months. 180 overweight subjects received CLA (as free fatty acid or triglyceride) or placebo. The CLA groups showed a 9% reduction in body fat and a 2% increase in lean mass compared to baseline. However, absolute fat loss compared to placebo was modest, and the percentage-based reporting made the results appear more impressive than they were in absolute terms.

Gaullier et al. (2005) – Journal of Nutrition: A 2-year extension study. 134 participants from the original trial continued for an additional 12 months. Those who took CLA for both years showed a 6-8% reduction in body fat mass from baseline. Those who switched from placebo to CLA in year two showed benefits. This confirmed that CLA’s effects are maintained but do not continue to increase substantially beyond 6 months. PMID: 15795434

Steck et al. (2007): A 12-week study in overweight adults that showed a modest reduction in body fat with CLA supplementation, but also noted adverse effects on blood lipid profiles.

The Isomer Problem: Half of Your CLA Supplement May Be Doing Nothing for Fat Loss

#

This is one of the most important and least discussed issues with CLA supplements. Understanding it reveals why the real effective dose is probably half of what you think you are taking.

Why It Matters

#

As described earlier, only the t10,c12 isomer has demonstrated fat-reducing effects in humans. The c9,t11 isomer, which is the predominant natural form in food, does not reduce body fat. In fact, research suggests these two isomers have fundamentally different and sometimes opposing biological activities:

• t10,c12 CLA: Reduces body fat by inhibiting lipoprotein lipase, suppressing PPARgamma signaling, inducing adipocyte apoptosis, and increasing CPT-1 activity. However, it also increases insulin resistance, promotes inflammation through NF-kappaB activation, and may increase liver fat.
• c9,t11 CLA: Has anti-inflammatory properties, is incorporated into skeletal muscle phospholipids, and may have anti-carcinogenic effects. It does not significantly affect body fat stores.

The Supplement Math Problem

#

Most commercial CLA supplements, including the widely studied Tonalin/Clarinol formulations, contain approximately a 50:50 ratio of c9,t11 and t10,c12 isomers. When a supplement label says “1,000 mg of CLA per softgel,” roughly 500 mg is the t10,c12 isomer that may reduce body fat, and roughly 500 mg is the c9,t11 isomer that does not.

This means that when studies use 3.2 g/day of mixed-isomer CLA and find a fat loss of 0.09 kg/week, the effective dose of the active isomer is actually only about 1.6 g/day. The fat loss effect is being diluted by including a non-active isomer.

Why Not Just Take Pure t10,c12 CLA?

#

This seems like an obvious solution, but the Riserus 2002 study demonstrated exactly why it is problematic. When researchers gave abdominally obese men purified t10,c12 CLA at 3.4 g/day, the subjects experienced a 19% increase in insulin resistance, a 4% increase in blood glucose, and a 4% decrease in HDL cholesterol compared to placebo. The mixed isomer CLA, by contrast, did not cause these metabolic disturbances (though it also produced less fat loss).

This suggests that the c9,t11 isomer may actually serve a buffering role, partially offsetting the metabolic harm caused by t10,c12. Removing it might increase the fat loss effect slightly but at the cost of significantly worsened metabolic side effects.

It is, to use a clinical understatement, not an ideal situation for a fat loss supplement.

Safety Concerns: What CLA Supplement Labels Do Not Tell You

#

CLA has been granted Generally Recognized as Safe (GRAS) status in the United States, which means it can be added to foods and sold as a supplement. However, GRAS status does not mean “no safety concerns exist.” It means the available evidence does not indicate a clear danger at standard doses in healthy populations. The nuances matter enormously.

Insulin Resistance

#

This is the most concerning safety signal in the CLA literature.

Riserus et al. (2002) – Diabetes Care: In a randomized, double-blind controlled trial, 60 abdominally obese men received either 3.4 g/day of purified t10,c12 CLA, 3.4 g/day of a mixed CLA isomer blend, or placebo for 12 weeks. The purified t10,c12 group showed a 19% increase in insulin resistance (measured by HOMA-IR), a 4% increase in fasting blood glucose, and reduced HDL cholesterol. The mixed isomer group did not show these effects. PMID: 12196420

Implications: People with existing insulin resistance, type 2 diabetes, metabolic syndrome, or prediabetes should exercise extreme caution with CLA supplements. The isomer responsible for fat loss (t10,c12) is the same one that worsens insulin sensitivity. This creates a paradox: the people who most want to lose body fat for metabolic health are the same people most vulnerable to CLA’s metabolic side effects.

Liver Fat Accumulation

#

Animal studies have consistently shown that CLA supplementation, particularly the t10,c12 isomer, can cause hepatic steatosis (fatty liver disease) at higher doses. Research in mice has demonstrated increased liver fat accumulation and inflammatory markers associated with non-alcoholic steatohepatitis.

In humans, the evidence is less clear but still concerning. Some trials have observed modest increases in markers of liver inflammation with CLA use. One 12-week study in obese women specifically examined liver safety and found that CLA did not significantly increase liver fat at standard doses, but the study duration may have been too short to detect chronic effects.

Given the growing prevalence of non-alcoholic fatty liver disease (affecting an estimated 25% of adults globally), adding a supplement with even theoretical hepatotoxic potential requires careful consideration.

Lipid Profile Changes

#

Multiple studies have reported that CLA supplementation can:

• Reduce HDL (“good”) cholesterol by 2 to 4%
• Modestly increase LDL cholesterol in some populations
• Increase markers of lipid peroxidation (oxidative damage to fats)

While these changes are individually small, they trend in the wrong direction for cardiovascular health. For someone already at elevated cardiovascular risk, even modest adverse lipid changes deserve attention.

Inflammatory Markers

#

The mechanistic research reveals a troubling pattern. The t10,c12 isomer activates NF-kappaB signaling in adipocytes, which triggers production of inflammatory cytokines including TNF-alpha, IL-6, and IL-8. This is the same inflammatory pathway implicated in obesity-related metabolic disease.

In other words, the mechanism by which CLA reduces fat in adipocytes (by promoting inflammation and apoptosis within fat tissue) is inherently pro-inflammatory. Whether this local adipose inflammation has systemic consequences in humans at standard supplement doses remains an open question, but the mechanism is concerning.

Gastrointestinal Side Effects

#

The most commonly reported side effects in clinical trials are gastrointestinal:

• Nausea
• Diarrhea
• Stomach upset and bloating
• Loose stools
• Fatigue

These effects are generally mild and tend to diminish with continued use, but they are consistent across studies and affect a meaningful percentage of participants.

Who Should Avoid CLA Supplements

#

Based on the available evidence, the following groups should not take CLA supplements without explicit medical supervision:

• People with type 2 diabetes or prediabetes
• People with metabolic syndrome
• People with non-alcoholic fatty liver disease
• People taking blood-thinning medications (including warfarin)
• People with existing cardiovascular disease or high LDL cholesterol
• Pregnant or breastfeeding women (insufficient safety data)
• Children and adolescents (insufficient safety data)

CLA for Athletes and Bodybuilders: Does It Help with Body Recomposition?

#

CLA has a devoted following in the bodybuilding and sports nutrition community. The appeal is straightforward: a supplement that reduces body fat while preserving or even increasing lean mass sounds like the holy grail of body recomposition. The reality, as with most CLA claims, is far more modest.

The Pinkoski Study (2006)

#

One of the most frequently cited studies in the fitness community is by Pinkoski and colleagues, who examined CLA supplementation during a 7-week resistance training program. They found that the CLA group gained slightly more lean mass than the placebo group during the training period. The effect was attributed to CLA’s potential interference with fatty acid metabolism of inflammatory proteins involved in muscle protein breakdown.

However, the lean mass difference was small, and subsequent studies have not consistently replicated this finding.

Cornish et al. (2009)

#

This study combined CLA with creatine monohydrate and whey protein during a strength training program. The combination group showed improvements in lean mass and strength, but the study design made it impossible to isolate CLA’s independent contribution from the well-established effects of creatine and protein supplementation.

Kreider et al. (2002)

#

In a study of experienced resistance-trained individuals, CLA supplementation during training did not significantly affect body composition, bone density, strength, or selected hematological markers compared to placebo. This is important because it tested CLA in exactly the population that most commonly uses it (trained lifters), and found no benefit. PMID: 12173945

Zambell et al. (2000)

#

A study in middle-aged men engaged in a resistance training program found that CLA supplementation did not reduce visceral adipose tissue, the type of abdominal fat most strongly associated with metabolic disease risk.

#

Where to Buy Quality Supplements

#

Based on the research discussed in this article, here are some high-quality options:

• Magnesium Supplement
• Protein Supplement
• Whey Protein Supplement
• Creatine Supplement

The Bottom Line for Athletes

#

The evidence does not support CLA as a meaningful body recomposition supplement. The Schoeller 2009 meta-analysis found only 0.3 kg of additional lean mass across all populations studied, not specifically in athletes. For trained individuals, the effect is likely even smaller or nonexistent.

Athletes seeking body recomposition would be far better served by optimizing protein intake (1.6 to 2.2 g/kg/day), following a structured progressive resistance training program, and managing caloric intake carefully. These interventions have effect sizes that are orders of magnitude larger than anything CLA can offer.

Creatine monohydrate, which has decades of research supporting lean mass gains of 1 to 2 kg during resistance training, remains the only supplement with robust evidence for improving body composition in athletes. CLA is not in the same category.

CLA Myths Debunked: What the Marketing Gets Wrong

#

Myth 1: “CLA Burns Fat Like It Does in Animal Studies”

#

Reality: Mouse studies showed 57 to 70% reductions in body fat. Human meta-analyses show 0.05 to 0.09 kg per week. The translation factor from mouse to human was roughly 1/50th to 1/100th of what the animal data predicted. Citing animal study results to sell a human supplement is misleading, and supplement companies that prominently feature mouse study data in their marketing materials know this.

Myth 2: “CLA Targets Belly Fat Specifically”

#

Reality: No supplement selectively removes abdominal fat. CLA does not appear to have any preferential effect on visceral adipose tissue. The Zambell study specifically tested this and found no effect on visceral fat in men doing resistance training. Fat loss from CLA, to the extent it occurs at all, is systemic and follows genetically determined patterns of fat mobilization.

Myth 3: “You Can Get Enough CLA from Grass-Fed Dairy and Beef”

#

Reality: Even the richest dietary sources provide only 0.5 to 1.5 grams of CLA per day, far below the 3.2 g/day study dose. More importantly, approximately 80% of dietary CLA is the c9,t11 isomer, which does not affect body fat. You would need to consume impractical quantities of dairy fat to approach the effective dose of the t10,c12 isomer, and doing so would add thousands of calories to your daily intake, entirely defeating the purpose.

Myth 4: “CLA Builds Lean Muscle”

#

Reality: The Schoeller 2009 meta-analysis found a 0.3 kg increase in fat-free mass, a change so small it is within measurement error for most body composition methods. A single week of structured resistance training produces more lean mass gain than CLA does over months of supplementation. Calling CLA a “muscle builder” is a significant stretch of the evidence.

Myth 5: “Higher Doses of CLA Produce Better Results”

#

Reality: The Blankson 2000 study specifically tested this by comparing doses of 1.7, 3.4, 5.1, and 6.8 grams per day. No additional benefit was observed above 3.4 g/day. Taking more CLA does not produce more fat loss. It may, however, increase the risk of side effects, particularly insulin resistance and gastrointestinal distress.

Myth 6: “CLA Is Completely Safe Because It Has GRAS Status”

#

Reality: GRAS status means CLA is considered safe for the general population at standard doses based on currently available evidence. It does not mean CLA is safe for everyone, in every dose, or that long-term concerns do not exist. The Riserus 2002 study demonstrated that purified t10,c12 CLA increased insulin resistance by 19% in abdominally obese men. GRAS status was granted based primarily on studies in healthy adults at standard mixed-isomer doses.

Myth 7: “CLA Prevents Weight Regain After Dieting”

#

Reality: The Gaullier 2005 two-year extension study is sometimes cited to support this claim. While participants who took CLA for two years maintained modest body fat reductions, the absolute amount of fat regain prevention was small, and the study design (an open-label extension of an earlier RCT) was not rigorous enough to draw strong conclusions about weight maintenance.

What Actually Works Better Than CLA for Fat Loss

#

Given CLA’s extremely modest effect size, virtually every evidence-based fat loss intervention produces superior results. Here is how CLA compares:

Caloric Deficit Through Diet

#

A 500 calorie per day deficit produces approximately 0.45 kg (1 pound) of fat loss per week. This is 5 to 9 times the fat loss rate of CLA supplementation. Dietary modification through portion control, reduced calorie-dense foods, and increased protein intake remains the single most effective fat loss intervention. No supplement comes close.

Regular Exercise

#

Structured exercise programs combining resistance training and cardiovascular training produce fat loss of 1 to 3 kg over 12 weeks in most studies, even without dietary changes. This is comparable to CLA’s effect over 6 to 12 months, achieved in one-quarter to one-half the time. Resistance training additionally preserves lean mass during weight loss far more effectively than any supplement.

Evidence-Based Supplements with Larger Effect Sizes

#

Caffeine: Increases resting metabolic rate by 3 to 11% and enhances fat oxidation. The acute thermogenic effect is approximately 100 to 200 additional calories burned per day at moderate doses (200 to 400 mg). Over 12 weeks, this produces more fat loss than CLA.

Green tea extract (EGCG): Meta-analyses show a modest but real increase in energy expenditure and fat oxidation, particularly when combined with caffeine. Effect sizes are comparable to or slightly larger than CLA, with a better safety profile.

Protein supplementation: Higher protein intake (1.6 to 2.2 g/kg/day) enhances satiety, increases the thermic effect of food, and preserves lean mass during caloric restriction. The body composition benefits of adequate protein intake substantially exceed what CLA can deliver.

Fiber supplementation: Glucomannan and psyllium husk have been shown in meta-analyses to reduce body weight by 0.8 to 1.5 kg over 4 to 12 weeks through appetite suppression and caloric displacement. This is comparable to CLA’s total effect but through a completely different and arguably safer mechanism.

The Cost-Benefit Reality

#

A typical CLA supplement costs $20 to $40 per month for the recommended 3.2 g/day dose. Over 6 months, that is $120 to $240 spent for an expected fat loss of approximately 1.3 kg. The same money could fund a gym membership, a supply of protein powder, or simply better quality food, all of which would produce meaningfully better results.

Drug Interactions and Medical Safety Considerations

#

Blood-Thinning Medications

#

CLA may have mild antiplatelet effects and could theoretically increase the risk of bleeding when combined with anticoagulant or antiplatelet medications. This includes:

• Warfarin (Coumadin)
• Aspirin (at therapeutic doses)
• Clopidogrel (Plavix)
• Heparin and low-molecular-weight heparins
• Direct oral anticoagulants (DOACs)

If you take any blood-thinning medication, do not start CLA without consulting your prescribing physician.

Diabetes Medications

#

Given CLA’s potential to increase insulin resistance (particularly the t10,c12 isomer), combining CLA with diabetes medications could complicate blood sugar management. This is especially relevant for:

• Insulin therapy (CLA may increase insulin requirements)
• Sulfonylureas (altered glucose dynamics)
• Metformin (opposing effects on insulin sensitivity)

People with type 2 diabetes should avoid CLA or use it only under close medical monitoring with regular glucose checks.

Blood Pressure Medications

#

CLA may modestly reduce blood pressure in some individuals. Combining CLA with antihypertensive medications could theoretically produce additive blood pressure lowering. While this interaction is likely clinically insignificant for most people, those on aggressive blood pressure regimens should be aware.

Surgery

#

Due to potential antiplatelet effects, CLA should be discontinued at least 2 weeks before any scheduled surgical procedure. Inform your surgeon and anesthesiologist about all supplements you take.

General Medical Advice

#

As with any supplement, discuss CLA with your healthcare provider before starting, especially if you:

• Take any prescription medications
• Have a chronic medical condition
• Have a history of liver disease
• Are pregnant, planning pregnancy, or breastfeeding
• Are under 18 years of age

Product Recommendations: CLA and Better Alternatives

#

If after reading the evidence above you still want to try CLA, the following products use the standardized CLA formulations that were tested in clinical trials. We also include supplements with stronger evidence for body composition that may be worth considering instead.

CLA Products

#

Swanson CLA 1,000 mg: Swanson provides high-quality CLA softgels derived from safflower oil. Each softgel contains 1,000 mg of CLA (800 mg active CLA). The standard dose is 4 softgels per day with meals to reach the 3.2 g study dose. Swanson is a well-established supplement brand known for quality and value.

Swanson Maximum Strength CLA: Another option from Swanson that provides a concentrated dose of conjugated linoleic acid from safflower oil. Swanson offers reliable third-party testing and transparent sourcing at a competitive price point.

Better-Supported Alternatives

#

Creatine Monohydrate: If your goal is body recomposition (losing fat while maintaining or gaining lean mass), creatine has vastly more evidence than CLA. Decades of research support lean mass gains of 1 to 2 kg during resistance training with 3 to 5 g/day. It is also one of the most affordable supplements available.

Whey Protein Isolate: Higher protein intake is one of the most reliable evidence-based strategies for improving body composition. A 25 to 40 g serving of whey protein supports muscle protein synthesis, increases satiety, and has a high thermic effect.

References

#

1. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997;32(8):853-858. PMID: 9270977

2. Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. American Journal of Clinical Nutrition. 2007;85(5):1203-1211. PMID: 17490954

3. Onakpoya IJ, Posadzki PP, Watson LK, Davies LA, Ernst E. The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials. European Journal of Nutrition. 2012;51(2):127-134. PMID: 21990002

4. Schoeller DA, Watras AC, Whigham LD. A meta-analysis of the effects of conjugated linoleic acid on fat-free mass in humans. Applied Physiology, Nutrition, and Metabolism. 2009;34(5):975-978. PMID: 19935864

5. Haghighat N, Rajabi S, Mohammadshahi M, et al. The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: a systematic review and dose-response meta-analysis. British Journal of Nutrition. 2024;131(3):466-486. PMID: 37671495

6. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. Journal of Nutrition. 2000;130(12):2943-2948. PMID: 11110851

7. Gaullier JM, Halse J, Hoye K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. American Journal of Clinical Nutrition. 2004;79(6):1118-1125. PMID: 15159244

8. Gaullier JM, Halse J, Hoye K, et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. Journal of Nutrition. 2005;135(4):778-784. PMID: 15795434

9. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002;25(9):1516-1521. PMID: 12196420

10. Kennedy A, Martinez K, Schmidt S, Mandrup S, LaPoint K, McIntosh M. Antiobesity mechanisms of action of conjugated linoleic acid. Journal of Nutritional Biochemistry. 2010;21(3):171-179. PMID: 19954947

11. den Hartigh LJ. Conjugated linoleic acid effects on cancer, obesity, and atherosclerosis: a review of pre-clinical and human trials with current perspectives. Nutrients. 2019;11(2):370. PMID: 30754681

12. Lehnen TE, da Silva MR, Camacho A, Marcadenti A, Lehnen AM. A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism. Journal of the International Society of Sports Nutrition. 2015;12:36. PMID: 26388708

13. Kreider RB, Ferreira MP, Greenwood M, et al. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. Journal of Strength and Conditioning Research. 2002;16(3):325-334. PMID: 12173945

14. Pinkoski C, Chilibeck PD, Candow DG, et al. The effects of conjugated linoleic acid supplementation during resistance training. Medicine and Science in Sports and Exercise. 2006;38(2):339-348. PMID: 16531905

15. Terpstra AH. Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. Journal of Nutrition. 2001;131(7):2067-2068. PMID: 11435530

16. Larsen TM, Toubro S, Gudmundsen O, Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. American Journal of Clinical Nutrition. 2006;83(3):606-612. PMID: 16522907

17. Zambell KL, Keim NL, Van Loan MD, et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids. 2000;35(7):777-782. PMID: 10941878

18. Mougios V, Matsakas A, Petridou A, et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. Journal of Nutritional Biochemistry. 2001;12(10):585-594. PMID: 12031264

19. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. Journal of Nutritional Biochemistry. 2006;17(12):789-810. PMID: 16650752

20. Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. Journal of Nutrition. 2008;138(8):1445-1451. PMID: 18641189

21. Raff M, Tholstrup T, Basu S, Nonboe P, Sorensen MT, Straarup EM. A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. Journal of Nutrition. 2008;138(3):509-514. PMID: 18287359

22. Benjamin S, Prakasan P, Sreedharan S, Wright AD, Spener F. Pros and cons of CLA consumption: an insight from clinical evidences. Nutrition and Metabolism. 2015;12:4. PMID: 25675136

23. Brownbill RA, Petrosian M, Ilich JZ. Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. Journal of the American College of Nutrition. 2005;24(3):177-181. PMID: 15930483

24. Watras AC, Buchholz AC, Close RN, Zhang Z, Schoeller DA. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. International Journal of Obesity. 2007;31(3):481-487. PMID: 16924272

25. Daley CA, Abbott A, Doyle PS, Nader GA, Larson S. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutrition Journal. 2010;9:10. PMID: 20219103

Common Questions About Cla For

#

What are the benefits of cla for?

Cla For has been studied for various potential health benefits. Research suggests it may support several aspects of health and wellness. Individual results can vary. The strength of evidence differs across different claimed benefits. More high-quality research is often needed. Always review the latest scientific literature and consult healthcare professionals about whether cla for is right for your health goals.

Is cla for safe?

Cla For is generally considered safe for most people when used as directed. However, individual responses can vary. Some people may experience mild side effects. It’s important to talk with a healthcare provider before using cla for, especially if you have existing health conditions, are pregnant or nursing, or take medications.

How does cla for work?

Cla For works through various biological mechanisms that researchers are still studying. Current evidence suggests it may interact with specific pathways in the body to produce its effects. Always consult with a healthcare provider before starting any new supplement or health regimen to ensure it’s appropriate for your individual needs.

Who should avoid cla for?

Cla For is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use cla for, consult with a qualified healthcare provider who can consider your complete health history and current medications.

What are the signs cla for is working?

Cla For is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use cla for, consult with a qualified healthcare provider who can consider your complete health history and current medications.

How long should I use cla for?

The time it takes for cla for to work varies by individual and depends on factors like dosage, consistency of use, and individual metabolism. Some people notice effects within days, while others may need several weeks. Research studies typically evaluate effects over weeks to months. Consistent use as directed is important for best results. Keep a journal to track your response.

Frequently Asked Questions

#

What is Cla and how does it work?

#

Cla is a compound that works through multiple biological pathways. Research shows it supports various aspects of health through its bioactive properties.

How much Cla should I take daily?

#

Typical dosages range from the amounts used in clinical studies. Always consult with a healthcare provider to determine the right dose for your individual needs.

What are the main benefits of Cla?

#

Cla has been studied for multiple health benefits. Clinical research demonstrates effects on various body systems and functions.

Are there any side effects of Cla?

#

Cla is generally well-tolerated, but some people may experience mild effects. Consult a healthcare provider if you have concerns or pre-existing conditions.

Can Cla be taken with other supplements?

#

Cla can often be combined with other supplements, but interactions are possible. Check with your healthcare provider about your specific supplement regimen.

How long does it take for Cla to work?

#

Effects can vary by individual and the specific benefit being measured. Some effects may be noticed within days, while others may take weeks of consistent use.

Who should consider taking Cla?

#

Individuals looking to support the health areas addressed by Cla may benefit. Those with specific health concerns should consult a healthcare provider first.